Abstract
Introduction Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis with no FDA-approved treatment. The complement pathway has received renewed a......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
